ID   USP-91
AC   CVCL_H634
DR   Wikidata; Q54991936
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8400235;
RX   PubMed=15356658;
CC   Doubling time: 26 hours (PubMed=8400235).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=8400235; DOI=10.1182/blood.V82.6.1829.1829;
RA   Umiel, Tehila
RA   Rettenmier, Carl Wayne
RA   Siegel, Stuart
RA   Ota, Shigeru
RA   Shimada, Hiroyuki
RA   Tran, Tuan W.
RA   Pattengale, Paul K.
RT   "Establishment and characterization of a human mixed-lineage,
RT   T-lymphoid/myeloid cell line (USP-91).";
RL   Blood 82:1829-1837(1993).
//
RX   PubMed=15356658; DOI=10.1038/sj.leu.2403465;
RA   Drexler, Hans Gunther
RA   MacLeod, Roderick A.F.
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   anaplastic large-cell lymphoma.";
RL   Leukemia 18:1569-1571(2004).
//